PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
04-Oct-2024 Tower Launches Customer Sustainability Hub with Practical Tools for Lower-Impact Pharmaceutical Cold Chain Tower Cold Chain
03-Oct-2024 Coronado Research announce engagement of Rob Nichols to support the growth of their Clinical Technology Practice Coronado Research
03-Oct-2024 PHARMASEAL AND LEDGER RUN FORGE PARTNERSHIP TO ENHANCE CLINICAL BUSINESS OPERATIONS PHARMASEAL
03-Oct-2024 White City Place signs landmark tenant Imperial College London, continuing rapid growth as part of leading UK life sciences and technology district Stanhope
03-Oct-2024 Lundbeck initiates clinical trial in immunology for Lu AG22515 in Thyroid Eye Disease H. Lundbeck A/S
03-Oct-2024 ProductLife Group (PLG) Acquires Nextep to Further Expand its Global Patient Access Capabilities ProductLife Group
03-Oct-2024 MitoRx Therapeutics Strengthens Leadership with Key Appointments as it Reveals Obesity Programme MitoRx Therapeutics
03-Oct-2024 Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma Recursion
03-Oct-2024 European Commission approves Yuvanci® (Single Tablet Combination Therapy [STCT] of Macitentan and Tadalafil) for Treatment of Patients with Pulmonary Arterial Hypertension (PAH) Janssen-Cilag International NV
01-Oct-2024 New Pharmanovia Study Results Reveal Chloral Hydrate Noticeably Improves Severe Insomnia Within Two Weeks Pharmanovia
01-Oct-2024 Neuraxpharm expands operations into the Middle East Neuraxpharm
01-Oct-2024 CSL Behring granted positive reimbursement recommendation for Haemophilia B Gene Therapy, HEMGENIX® in Spain CSL
01-Oct-2024 Abzena Expands Partnership with ProteoNic to Include 2G UNic® Technology as Standard Offering for All Customers ProteoNic
01-Oct-2024 Nxera Pharma Enters New Commercial Partnership with Shionogi for QUVIVIQ™ in Japan Nxera Pharma
01-Oct-2024 Tessellate BIO, Omico and CMRI announce a multi-year collaboration to accelerate discovery of synthetic lethal precision therapies to address ‘ALT’ cancers Tessellate BIO
01-Oct-2024 PureTech to Present at CHEST 2024 Annual Meeting PureTech Health
01-Oct-2024 IBRILATAZAR (ABTL0812) from AbilityPharma increases chemotherapy effectiveness by 40% in patients with endometrial cancer AbilityPharma
01-Oct-2024 How to Find the Best Clinical Research Course for Your Career Goals Fusion technology solutions
30-Sep-2024 IGI Announces CRADA with National Cancer Institute to Test Proprietary Oral Cbl/b Inhibitor Treatment in Triple Negative Breast Cancer Ichnos Glenmark Innovation (IGI),
30-Sep-2024 European Commission approves Yuvanci® (Single Tablet Combination Therapy [STCT] of Macitentan and Tadalafil) for Treatment of Patients with Pulmonary Arterial Hypertension (PAH) Johnson & Johnson